Concepedia

Sewanti Limaye

SL

Statistics

Publications

12

Citations

856

H-Index

12

Active since

2008

Affiliations

Datar Cancer Genetics (India)(Current)

Sir H.N. Reliance Foundation Hospital and Research Centre

Worcester Polytechnic Institute

Kokilaben Dhirubhai Ambani Hospital

Cancer Clinic

Sewanti Limaye is an author at Datar Cancer Genetics (India) specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2008–2025

12

Publications

12

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

, , +16

Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial

Bradley J. Monk, Takafumi Toita, Xiaohua Wu et al. · The Lancet Oncology · 2023 · 204 citations

, , +12

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

C. Benedikt Westphalen, Diogo Martins-Branco, Juliana Rodrigues Beal et al. · Annals of Oncology · 2024 · 55 citations · Full text

, , +14

Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer

Dadasaheb Akolkar, Darshana Patil, Timothy Crook et al. · International Journal of Cancer · 2019 · 49 citations · Full text

, , +17

EGFR Expression in Gallbladder Carcinoma in North America

Matthew Kaufman, Bhoomi Mehrotra, Sewanti Limaye et al. · International Journal of Medical Sciences · 2008 · 48 citations · Full text

, , +13

1–5 of 12